Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Similar long‐term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV‐1‐infected patients in a retrospective, real‐life cohort of 14 years

Similar long‐term efficacy of dual therapy containing raltegravir and a boosted protease... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hiv Medicine Wiley

Similar long‐term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV‐1‐infected patients in a retrospective, real‐life cohort of 14 years

Loading next page...
 
/lp/wiley/similar-long-term-efficacy-of-dual-therapy-containing-raltegravir-and-Uf6L2BoXmI

References (8)

Publisher
Wiley
Copyright
HIV Medicine © 2018 British HIV Association
ISSN
1464-2662
eISSN
1468-1293
DOI
10.1111/hiv.12636
Publisher site
See Article on Publisher Site

Abstract

Journal

Hiv MedicineWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

There are no references for this article.